Immunotherapy of Malignant Tumors Using Antisense Anti-IGF-I Approach: Case of Glioblastoma

ISSN Print: 2151-1934
ISSN Online: 2151-1942
www.scirp.net/journal/jct
E-mail: [email protected]

Citations

"Immunotherapy of Malignant Tumors Using Antisense Anti-IGF-I Approach: Case of Glioblastoma"
written by Annabelle Trojan, Lina M. Jay, Heliodor Kasprzak, Donald D. Anthony, Jerzy Trojan,
published by Journal of Cancer Therapy, Vol.5 No.7, 2014

has been cited by the following article(s):

[1]	Diagnostic of CNS neoplasia–AFP and IGF-I targets
	2020

[2]	Neoplastic Brain, Glioblastoma, and Immunotherapy
	2020

[3]	Clinical gene therapy of brain tumor–glioblastoma
	2020

[4]	Hyperthyroidism
	2020

[5]	Experimental gene therapy of CNS neoplasia–IGF-I target
	2020

[6]	Twenty-Five Years of Cancer Immunogene Therapy: Anti-Gene IGF-I Approach
	2019

[7]	Oncoproteins Targeting: Antibodies, Antisense, Triple-helix. Case of Anti IGF-I Cancer Immunogene Therapy
	2019

[8]	Epistemológica experiencia en la elaboración de tecnología biomolecular para estrategia de la inmunoterapia génica-Epistemological experience in the …
	2016

[9]	Epistemológica experiencia en la elaboración de tecnología biomolecular para estrategia de la inmunoterapia génica
	2016

[10]	Growth factors and kinases in glioblastoma growth
	2016

[11]	Experiencia epistemologica en la elaboracion de tecnologia biomolecular como estrategia de la inmunoterapia genica/Epistemological experience in developing of …
	2016

[1]	Brain and Spinal Tumors - Primary and Secondary 2020 DOI:10.5772/intechopen.84726

[2]	Antisense Therapy [Working Title] 2019 DOI:10.5772/intechopen.82548